Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Myriad Genetics, Inc. - Common Stock (NQ:MYGN)

4.750 +0.110 (+2.37%)
Official Closing Price Updated: 4:15 PM EDT, Mar 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,773,422
Open 4.540
Bid (Size) 4.300 (600)
Ask (Size) 4.800 (2,000)
Prev. Close 4.640
Today's Range 4.540 - 4.800
52wk Range 3.760 - 10.30
Shares Outstanding 93,500,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer
Approval reinforces Myriad’s leadership in comprehensive HRD testing and establishes MyChoice CDx as the only FDA-approved companion diagnostic for Zejula in the United States 
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
2 High-Flying Stocks with Competitive Advantages and 1 We Brush Off
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the ... 
Via StockStory

Performance

YTD
-22.6%
-22.6%
1 Month
+5.6%
+5.6%
3 Month
-29.1%
-29.1%
6 Month
-38.2%
-38.2%
1 Year
-52.2%
-52.2%

More News

Read More
News headline image
Stocks making big moves yesterday: nLIGHT, Myriad Genetics, Vertex Pharmaceuticals, Nextpower, and Teladoc
Via StockStory
Topics Artificial Intelligence
Myriad Genetics Inc (NASDAQ:MYGN) Stock Surges 19.6% on Strong Q4 Earnings Beat ↗
Via Chartmill
News headline image
3 Reasons to Sell MYGN and 1 Stock to Buy Instead
Via StockStory
News headline image
Myriad Genetics (MYGN) Shares Skyrocket, What You Need To Know
Via StockStory
Topics Artificial Intelligence Earnings
News headline image
3 Stocks Under $10 We Keep Off Our Radar
Via StockStory
News headline image
2 Unprofitable Stocks on Our Buy List and 1 We Brush Off
Via StockStory
News headline image
Myriad Genetics (MYGN) Stock Trades Up, Here Is Why
Via StockStory
Topics Earnings Economy Stocks
News headline image
Myriad Commercially Launches Precise MRD with Select Community Oncologists
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know
Via StockStory
Topics Economy Government Stocks
News headline image
Why Myriad Genetics (MYGN) Stock Is Trading Up Today
Via StockStory
Topics Government World Trade
News headline image
Six presented abstracts at ASCO-GU 2026 reinforce the clinical impact of Myriad’s Precise MRD, Prolaris, and MyRisk tests
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Myriad Genetics (MYGN) Q4 2025 Earnings Transcript ↗
Via The Motley Fool
What's going on in today's after hours session ↗
Via Chartmill
News headline image
Myriad Genetics’s (NASDAQ:MYGN) Q4 CY2025 Sales Top Estimates, Stock Jumps 22%
Via StockStory
News headline image
Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
iRhythm, agilon health, GoodRx, Fortrea, and Myriad Genetics Stocks Trade Down, What You Need To Know
Via StockStory
Topics Government World Trade
News headline image
FirstGene Study Demonstrates High Analytical Sensitivity and Specificity for Each Component of the Test
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
Myriad Genetics to Release Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
3 Cash-Burning Stocks We Keep Off Our Radar
Via StockStory
Topics Bankruptcy
News headline image
1 Small-Cap Stock on Our Watchlist and 2 That Underwhelm
Via StockStory
News headline image
Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data
From Myriad Genetics, Inc.
Via GlobeNewswire
News headline image
2 Healthcare Stocks with Solid Fundamentals and 1 That Underwhelm
Via StockStory
Topics Economy Stocks
News headline image
Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2025 Financial Results and Introduces Full Year 2026 Financial Guidance
From Myriad Genetics, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Myriad Genetics, Inc. - Common Stock publicly traded?
Yes, Myriad Genetics, Inc. - Common Stock is publicly traded.
What exchange does Myriad Genetics, Inc. - Common Stock trade on?
Myriad Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Myriad Genetics, Inc. - Common Stock?
The ticker symbol for Myriad Genetics, Inc. - Common Stock is MYGN on the Nasdaq Stock Market
What is the current price of Myriad Genetics, Inc. - Common Stock?
The current price of Myriad Genetics, Inc. - Common Stock is 4.750
When was Myriad Genetics, Inc. - Common Stock last traded?
The last trade of Myriad Genetics, Inc. - Common Stock was at 03/19/26 04:15 PM ET
What is the market capitalization of Myriad Genetics, Inc. - Common Stock?
The market capitalization of Myriad Genetics, Inc. - Common Stock is 444.12M
How many shares of Myriad Genetics, Inc. - Common Stock are outstanding?
Myriad Genetics, Inc. - Common Stock has 444M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.